idarubicin has been researched along with mitomycin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benfenati, E; Raska, I; Toropov, AA; Toropova, AP | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Behrens-Baumann, W; Bohnensack, R; Heilmann, C; Schlüter, T; Schönfeld, P | 1 |
| Arinç, E; Celik, H | 3 |
| Hasegawa, E; Hayami, N; Hiramatsu, R; Hoshino, J; Marui, Y; Sawa, N; Sumida, K; Suwabe, T; Takaichi, K; Takemoto, F; Tsuchiya, Y; Ubara, Y; Yamanouchi, M | 1 |
1 review(s) available for idarubicin and mitomycin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 other study(ies) available for idarubicin and mitomycin
| Article | Year |
|---|---|
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations.
Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water | 2010 |
Effect of the cytostatic agent idarubicin on fibroblasts of the human Tenon's capsule compared with mitomycin C.
Topics: Antibiotics, Antineoplastic; Apoptosis; Cell Count; Cell Division; Dose-Response Relationship, Drug; Fascia; Fibroblasts; Filtering Surgery; Humans; Idarubicin; Mitomycin; Oculomotor Muscles; Proline; Strabismus; Thymidine | 1999 |
Bioreduction of idarubicin and formation of ROS responsible for DNA cleavage by NADPH-cytochrome P450 reductase and its potential role in the antitumor effect.
Topics: Animals; Cytochrome P-450 Enzyme System; DNA; DNA Cleavage; Humans; Idarubicin; Lung; Microsomes; Mitomycin; NADP; NADPH-Ferrihemoprotein Reductase; Oxidation-Reduction; Reactive Oxygen Species; Sheep | 2008 |
Evaluation of the protective effects of quercetin, rutin, naringenin, resveratrol and trolox against idarubicin-induced DNA damage.
Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Chromans; DNA Breaks, Single-Stranded; DNA Damage; Dose-Response Relationship, Drug; Flavanones; Idarubicin; In Vitro Techniques; Mitomycin; NADPH-Ferrihemoprotein Reductase; Quercetin; Rabbits; Resveratrol; Rutin; Stilbenes | 2010 |
Successful treatment of acute promyelocytic leukemia in a patient on hemodialysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Idarubicin; Kidney Failure, Chronic; Leukemia, Promyelocytic, Acute; Middle Aged; Mitomycin; Remission Induction; Renal Dialysis; Tretinoin | 2011 |
Evaluation of bioreductive activation of anticancer drugs idarubicin and mitomycin C by NADH-cytochrome b5 reductase and cytochrome P450 2B4.
Topics: Animals; Antineoplastic Agents; Aryl Hydrocarbon Hydroxylases; Cattle; Cytochrome P450 Family 2; Cytochrome-B(5) Reductase; DNA Breaks; Idarubicin; Microsomes, Liver; Mitomycin; NAD; NADP; Oxidation-Reduction; Plasmids; Rabbits | 2013 |